Amundi
CME icon

Amundi’s CME Group CME Stock Holding History

Amundi’s Portfolio CME Stock Details CME Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$613M Buy
2,075,107
+250,780
+14% +$74.5M 0.17% 117
2025
Q4 		$498M Buy
1,824,327
+64,841
+4% +$17.6M 0.14% 154
2025
Q3 		$461M Sell
1,759,486
-227,861
-11% -$62M 0.15% 127
2025
Q2 		$548M Buy
1,987,347
+385,225
+24% +$105M 0.19% 102
2025
Q1 		$430M Sell
1,602,122
-576,014
-26% -$142M 0.16% 134
2024
Q4 		$500M Sell
2,178,136
-1,360,003
-38% -$313M 0.17% 125
2024
Q3 		$784M Buy
3,538,139
+936,829
+36% +$194M 0.29% 80
2024
Q2 		$510M Buy
2,601,310
+236,813
+10% +$48.9M 0.2% 117
2024
Q1 		$496M Buy
2,364,497
+74,611
+3% +$15.7M 0.21% 110
2023
Q4 		$451M Sell
2,289,886
-852,923
-27% -$182M 0.2% 120
2023
Q3 		$689M Sell
3,142,809
-155,426
-5% -$30.9M 0.34% 60
2023
Q2 		$614M Sell
3,298,235
-581,192
-15% -$107M 0.31% 76
2023
Q1 		$757M Buy
3,879,427
+1,150,551
+42% +$208M 0.41% 47
2022
Q4 		$479M Buy
2,728,876
+421,409
+18% +$73.2M 0.26% 99
2022
Q3 		$417M Sell
2,307,467
-326,107
-12% -$64.4M 0.25% 102
2022
Q2 		$525M Buy
2,633,574
+23,261
+0.9% +$4.93M 0.42% 47
2022
Q1 		$638M Buy
2,610,313
+214,943
+9% +$50.5M 0.43% 44
2021
Q4 		$536M Buy
2,395,370
+379,306
+19% +$83.5M 0.34% 69
2021
Q3 		$390M Sell
2,016,064
-98,576
-5% -$20M 0.27% 80
2021
Q2 		$450M Buy
+2,114,640
New +$446M 0.31% 64

Other funds holding CME

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
VPM
Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM
Capital World Investors
Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return
Bank of New York Mellon
Bank of New York Mellon New York $544B AUM 28.31% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return

Amundi's CME Position: Q1 2026 in Review

Amundi increased its CME Group (CME) stake by 14% in Q1 2026, buying an estimated $74.5M and bringing the position to 2,075,107 shares worth $613M. The position accounts for 0.17% of the portfolio, ranked #117.

Amundi first reported a position in CME in Q2 2021 and has held it in 20 quarters since. The position peaked at $784M in Q3 2024. 1,790 funds tracked by Wall St. Rank hold CME as of Q1 2026.

  • Amundi held 2,075,107 shares of CME Group worth $613M as of Q1 2026.
  • Amundi bought 250,780 CME Group shares in Q1 2026, an estimated $74.5M.
  • CME Group made up 0.17% of Amundi's portfolio in Q1 2026, its #117 holding.
  • Amundi first reported a position in CME Group in Q2 2021 and has held it in 20 quarters since.
  • Amundi's CME Group position peaked at $784M in Q3 2024.
  • 1,790 funds tracked by Wall St. Rank held CME Group as of Q1 2026.

Based on Amundi's 13F filing for Q1 2026, filed 18 May 2026.